Meet In CommonNewsRSS feeds

Local

Mike Sherzan announces independent run for Iowa Senate District 14

A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: Iowa Capital Dispatch

Mike Sherzan, a businessman and former candidate for Congress, announced Thursday he will run as an independent for the Iowa Senate seat left vacant by Democrat Sarah Trone Garriott’s election to Congress. Sherzan ran for Iowa’s 3rd Congressional District seat as a Democrat in 2014, 2016 and 2018. He withdrew from the race before the 2014 and 2018 primary; he lost to Jim Mowrer in the 2016 primary. Sherzan said in a news release that while he is a longtime Democrat, he is running as an independent for Iowa Senate District 14 because in a special election, major-party nominees are chosen by “party insiders” at convention rather than by party voters. “А full primary would be my first choice, but the special election process is what we currently have. I believe the people of Iowa’s 14th District should have a say about who their representative will be,” Sherzan said in a statement. “I respect the Democratic Party and the policies it stands for.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at Iowa Capital Dispatch

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

Community Poll

Organizations should help affected people recover after a personal-data breach.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Would you want a doctor to give you a fake pill if the lie might make you feel better?

A patient has persistent symptoms that have not responded to standard treatments. A harmless placebo may help, but its effect could weaken if the clinician fully explains that it contains no active medicine.

Can a beneficial deception respect the person it helps?

Explore this quandary